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Prevention of mother-to-child transmission (PMTCT)
programmes have been implemented in South Africa at
government-designated pilot sites and nationally, by order of a
July 2002 Constitutional Court judgement ordering the
government to make nevirapine (NVP) universally available to
HIV-infected pregnant women. The efficacy of local routine
services in comparison to research-based PMTCT programmes,
remains to be evaluated. The national PMTCT programme
offers voluntary counselling and testing, administration of
NVP to mother and baby,1 provision of free milk formula for
the first 6 months of life, and follow-up for infants on co-
trimoxazole prophylaxis from 6 weeks of age to 12 months of
age when their HIV infection status is determined using an
HIV enzyme-linked immunosorbent assay (ELISA) test. Earlier
HIV testing using HIV DNA PCR tests is considered too
expensive. Prolonged follow-up of large numbers of
predominantly HIV-uninfected children has resulted in poor
follow-up rates at government pilot sites. The outcome is a lack
of data on HIV transmission rates, undermining the
government's ability to assess the efficacy of local PMTCT
programmes. The supply of free milk formula is contentious
and presently under review, but in the absence of HIV
transmission rate data the prevalence and effect of breast-
feeding on the programme cannot be accurately assessed.
Coronation Women and Children’s Hospital (CWCH) has had
a formal PMTCT programme in place since October 2001
operating as a routine clinical service. Ongoing evaluation of
the PMTCT programme is essential to evaluate successes,
identify deficiencies and put systems in place to improve the
service. HIV-infected women and their children born at CWCH
from January to September 2002 had the opportunity to
participate in an infant HIV diagnostic study that would
determine the HIV infection status of the children at 4 months
of age. The study, approved by the Ethics Committee of the
University of the Witwatersrand, aimed to establish an
accurate, locally affordable infant HIV diagnostic protocol to
determine the HIV infection status of perinatally exposed
infants as early on in life as possible. This study provided an
opportunity to assess components of the routine PMTCT
service in a research setting.  
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Objectives. Assessment of the efficacy of a prevention of
mother-to-child transmission (PMTCT) programme in a
routine service setting in comparison to a research
environment.
Design. Descriptive study over a 13-month period utilising
retrospective data obtained from hospital records
complemented by prospective data on a sample of patients
enrolled in a study to determine an affordable HIV diagnostic
protocol for infants. 
Setting. Routine PMTCT service at Coronation Women and
Children's Hospital (CWCH) situated in Johannesburg and
affiliated to the University of the Witwatersrand. 
Subjects. Pregnant women known to be HIV infected who
delivered at CWCH from 1 October 2001 to 31 October 2002.
Outcome measures. The HIV transmission rate to infants, which
reflects nevirapine (NVP) delivery and infant feeding
practices, and follow-up rates of perinatally exposed children.
Results. Of the 8 221 deliveries, 1 234 (15%) occurred in
women known to be HIV infected. HIV transmission rates of
8.7% at 6 weeks and 8.9% at 3 months of age in the study
population verifies the high rate of NVP administration and
the ability of women to formula-feed their babies and abstain
from breast-feeding. More than one-third of infants never
return for follow-up and more than 70% are lost to follow-up
by 4 months of age.  
Conclusions. The low HIV transmission rate confirms the
efficacy of this routine service PMTCT programme. HIV-
infected children are not being identified for medical
management as part of PMTCT follow-up. It is imperative
that record keeping is improved to facilitate ongoing
monitoring. 
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Methods
Descriptive data on the PMTCT service were collected
retrospectively from labour ward, postnatal ward and
paediatric PMTCT follow-up clinic records over a 13-month
period from 1 October 2001 to 31 October 2002. The Ethics
Committee of the University of the Witwatersrand approved
collection of the retrospective data from hospital records. At the
time of discharge post delivery, all HIV-infected women on the
PMTCT programme were given a 2-week follow-up
appointment as a lead into the PMTCT follow-up service for
their infants. HIV-infected women delivering at CWCH were
eligible to participate in the infant diagnostic study if they gave
informed consent and could be contacted telephonically.
Enrolment of 300 infants was commenced in January 2002 and
all 6-week visits had been completed by October 2002. The 300
infants included 3 sets of twins, therefore 297 mothers were
enrolled. Infants failing to attend the 6-week visit by 8 weeks of
age were removed from the study. The minimum HIV testing
performed included a Roche Amplicor version 1.5 HIV DNA
PCR (Roche Molecular Systems, Basel, Switzerland) at 6 weeks
and 3 months of age and an HIV ELISA at 12 months of age. A
child was considered HIV-infected if the HIV DNA PCR results
at 6 weeks and 3 months of age were positive and there were
clinical stigmata of HIV infection. If these conditions did not
apply, a further clinical examination and HIV DNA PCR test
were performed at 4 months of age.2 Infants were deemed HIV-
uninfected if they had negative HIV DNA PCR results at both
the 6-week and 3-month visits with no overt clinical stigmata
of HIV infection. Infant feeding histories were noted at each
visit. In order to ensure good follow-up, mothers were
reminded of their appointments a week before their study visit.
If they failed to keep their appointments they were given
another. If they could not be contacted telephonically,
community workers visited them at home. Mothers' travel
costs were reimbursed at each visit. Patients not enrolled in the
study at 2 weeks were given appointments for a 6-week follow-
up visit and seen at the same outpatient clinic as the study
patients. They received no reminders and if they defaulted, no
further appointment was scheduled.
Results
Data extraction from current PMTCT records proved laborious
because they are not stringently kept and are in a fragmented
format with no central co-ordination. The poor accessibility of
the data made it difficult to measure all aspects of the PMTCT
programme. There were 8 221 deliveries documented at CWCH
over the 13-month period averaging 632 deliveries per month,
which included a median of 38 deliveries (6%) to women who
had not attended an antenatal clinic. HIV-infected women
accounted for a total of 1 234 of the deliveries, averaging 95 per
month, with 15 twin pregnancies. The HIV prevalence rate in
women attending the hospital's antenatal clinic who consent to
HIV testing is 15%, with a range of 14 -18% per month. The
official antenatal prevalence rate for the Johannesburg area in
2001 was 29.8%.3 The discrepancy in HIV prevalence rates may
be due to reduced uptake of HIV testing. Delivery before
reaching the hospital was the commonest reason for study
mothers not receiving NVP (Table I). The retrospective record
review and the study data concur in showing a high rate (≥
95%) of NVP administration to the baby and very few
documented cases of a lack of NVP administration to mother
(2%) and baby (< 1%). Poor documentation of NVP
administration to mothers compared with babies in the routine
setting may be a consequence of the environment in which
these records are maintained, viz. labour ward versus the more
stable and controlled environment of the postnatal wards. A
total of 794 (64%) of the babies born to HIV- infected women
were seen at some stage for medical evaluation within the
PMTCT programme after delivery. Fifty- six per cent of babies
(N = 705) returned for their 2-week visits. The follow-up rate
for children at the PMTCT outpatient clinic in the routine
service programme versus the research setting is illustrated in
Fig. 1. Follow-up rates are biased in favour of the study
patients by the study protocol, ensuring 100% follow-up at 6
weeks of age. By 31 October 2002 approximately the same
number of children had attended their 6-week visits in the
routine and research settings. By the 4-month visit, with
approximately the same number of study (19%) and routine
(25%) patients still due to attend, substantially more routine
patients (79%) than study patients (8%) had missed their
appointments (Fig. 1). The 7 - 9-month visit had similar
numbers of children due for their appointments in the study
(57%) and routine (62%) settings; however, the number of
children lost to follow-up continued to be strikingly
disproportionate at 14% and 75% respectively. In the routine
setting, 67 children were ≥ 12 months of age and therefore
eligible for HIV ELISA testing. No deaths were recorded in this
group of children and the lost to follow-up rate in this small
number of patients was 85%. 
Of the 1 234 women recorded to have participated in the
PMTCT programme 16  women (1.3%) reported breast-feeding
Table I. NVP administration in a routine versus a research
environment
Routine records Study records
NVP status Mother (%)   Baby (%) Mother (%) Baby (%)
NVP received 896 (73) 1198 (96) 288 (97) 297 (99)
NVP not received 30 (2) 7 (0.5) 7 (2) 2 (0.7)
No record of NVP 308 (25) 44 (3.5) 2 (1) 1 (0.3)
administration
Total 1 234 1 249 297 300
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their babies, 743 (60%) reported formula-feeding, and not
breast-feeding, and the feeding practices of 475 women (38%)
were unrecorded. In the study sample, 6 women (2%) reported
having breast-fed their infants and all had discontinued by 3
months of age. The 6-week HIV DNA PCR test results for the
300 study infants revealed 26 HIV-positive and 274 HIV-
negative results, an HIV transmission rate of 8.7%. At 3 months
of age, the HIV DNA PCR results concurred with the 6-week
PCR results in every case, however 7 patients who had tested
PCR-negative had been lost to follow-up. The 3-month HIV
transmission rate was 8.9%. The follow-up study visits
conducted to date have confirmed the final HIV status
determined at 4 months of age in all cases. 
Discussion
Evaluation of the first 13 months of the formal routine PMTCT
service at CWCH was considerably enhanced by the
availability of data collected in a research environment over the
same time period. The study enrolled 297 (24%) of the total
1 234 HIV-positive women registered with the PMTCT service,
therefore despite any bias introduced by the inclusion criteria
and study design the sample represents a significant
proportion of patient outcomes in the routine service.  
A single dose of NVP administered to the mother at the
onset of labour and to the baby within 72 hours of birth
significantly reduces MTCT of HIV (Table II).2 The low HIV
transmission rates achieved in a routine PMTCT programme at
CWCH surpass the best results achieved in research PMTCT
settings using NVP. If most women in the CWCH PMTCT
programme were breast-feeding, then according to the current
literature the expected transmission rate at 6 weeks and 3
months of age would be in the region of 11.9% and 13.1%
respectively.2 The MTCT rate documented in a predominantly
non-breast-feeding population at CWCH (~9%) at 6 weeks of
age versus the predominantly breast-feeding population in
HIVNET 012 (~12%) at 6 - 8 weeks, confirms previous
estimates that breast-feeding contributes an additional ~3% of
cases of HIV infection in the first 6 weeks of life (Table II).1,4,5
The reduction in MTCT of HIV achieved by the CWCH
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Table II.  Comparison of MTCT rates achieved using NVP in populations with variable rates of breast-feeding 
Increase in MTCT
% Women rate attributed to
Study breast-feeding MTCT rate (age in weeks) MTCT rate (age in weeks) breast-feeding (age in weeks)
HIVNET 012 1 > 95 11.9%  (6 - 8) 13.1%  (14 - 16) 3.6%  (6 - 8)
SAINT4 42 12.3%  (8) 5.6%  (8)
PEP5 17 13.4%  (6) 3.1%  (6)
CWCH PMTCT 2 8.7%  (6) 8.9% (14)
SAINT = South African Intrapartum Nevirapine Trial; PEP = Post-Exposure Prophylaxis Trial.
Fig. 1.  A and B. Visit attendance figures for routine patients exclude
study patients as additional resources were expended to ensure good
follow-up rates among the latter. ‘Visits due’ refers to visits during
the study period that infants could still be expected to attend when
they reached that specific age. C. The percentage of visits missed
increased with time in both settings but was strikingly higher in the
routine setting where almost 80% of children were lost 3 - 4 months
into the 12-month programme. Despite a research environment, the
loss to follow-up at 1 year approached 25%. 
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programme provides unequivocal confirmation that a routine
service programme is capable of delivering NVP to mothers
and babies and of supporting women to formula-feed instead
of breast-feeding. It is well documented that in communities in
developing countries formula-feeding and abstaining from
breast-feeding can be extremely difficult for women to
achieve,6,7 however the data suggest that women attending the
CWCH PMTCT service are highly motivated not to breast-feed
and are able to exercise this choice in the community. Factors
that are important in determining infant feeding practices in
this community of women (e.g. the PMTCT counselling
regarding infant feeding choices, the social environment,
disclosure of HIV status and provision of free milk formula as
part of the PMTCT programme) are currently under
investigation. Despite the difficulties surrounding infant
feeding practices, the MTCT data provide evidence that
women enrolled on the CWCH PMTCT programme managed
to use the free supply of milk formula to protect their babies
from contracting HIV infection. The national PMTCT protocol
makes provision for follow-up care of mothers and infants
beyond the time of birth; however the guidelines on the care of
children in South Africa have been described as 'largely
unrealistic'.8 The increased attrition rates over time were
anticipated, but the scale of the problem and the finding that
over 40% of children are lost as early as 2 - 6 weeks of age was
not. If no provision is made for follow-up care for children in
the PMTCT programmes then HIV-infected children will first
present for medical care when they develop symptoms of HIV
disease or die undiagnosed in their communities. The
opportunity to counsel, educate, medically manage and
support HIV-affected families will be lost, as will the ability to
monitor PMTCT programmes. Discontinuation of the follow-
up phase of the PMTCT programme is therefore an
unacceptable option. At CWCH the number of children
requiring follow-up per clinic has increased 3.5 fold from
October 2001 to January 2003. Additional resources in the form
of infrastructure and trained health care workers are necessary
to improve follow-up, particularly if current government
guidelines are pursued. Local clinics will need to be equipped
to assume responsibility for follow-up of children as part of the
routine well baby and immunisation services which would
have the advantage of strengthening the country's general
health care service.8 The infant HIV diagnostic protocols
developed in the First World require a minimum of two HIV
DNA PCR tests. Preliminary results of the infant diagnostic
study described here suggest that permutations of HIV testing
other than the extremes of two early HIV PCR tests versus a
late HIV ELISA test (advocated by the current national policy)
can be used with excellent results. Adapting infant HIV
diagnostic algorithms to suit specific local settings may prove
an alternative, cost-effective strategy for providing follow-up
care of infants in routine PMTCT programmes. Early diagnosis
of HIV infection status would dramatically reduce the number
of follow-up visits required for HIV-exposed children. The cost
effectiveness of this approach over providing the additional
resources needed to implement national guidelines is being
assessed.
Conclusion
This routine service PMTCT programme is highly effective in
reducing the MTCT rate of HIV but fails in follow-up of
children. The failure can be attributed predominantly to the
hospital's lack of capacity to implement the national
programme guidelines for follow-up of perinatally exposed
children. Women from the communities attending this PMTCT
programme are able to abstain from breast-feeding to reduce
MTCT.  Record keeping systems that document all facets of the
PMTCT service need to be designed to facilitate regular audit
and intervention. Cost-effective, early HIV diagnostic
algorithms will improve identification of HIV-infected children
and enable HIV-affected children to access appropriate health
care.
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